EUVIMEDEUVIMED entdecken
Open Access

Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021)

M A Pfaller, C G Carvalhaes iD, P R Rhomberg, L M Desphande, M Castanheira iD

Journal of Clinical Microbiology · 2024

DOI: 10.1128/jcm.01141-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von M A Pfaller und 4 weiteren Autor:innen. Beteiligte Einrichtung: JMI Laboratories , North Liberty, Iowa, USA. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Invasive Fungal Infections, Nitriles, Pyridines. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A few microbiology laboratories perform antifungal susceptibility testing locally for systemically active antifungal agents. The identification of emerging azole-resistant Aspergillus fumigatus is worrisome. As such, there is a critical role for antifungal surveillance in tracking emerging resistance among both common and uncommon opportunistic fungi. Differences in the regional prevalence and antifungal resistance of these fungi render local epidemiological knowledge essential for the care of patients with a suspected invasive fungal infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspergillus fumigatusInvasive Fungal InfectionsNitrilesPyridinesTriazolesHumansAzolesAntifungal AgentsFungiEuropeDrug Resistance, FungalMicrobial Sensitivity TestsFungal Proteins

Stichwörter der Autor:innen

A. fumigatusEuropeNorth Americaazolesresistancesurveillance studies

Substanzen

isavuconazoleAzolesAntifungal AgentsFungal ProteinsNitrilesPyridinesTriazoles

Autor:innen und Institutionen

  • JMI Laboratories , North Liberty, Iowa, USA.
  • University of Iowa , Iowa City, Iowa, USA.

ORCID-Profile: C G Carvalhaes, M Castanheira

Zitieren

APA

Pfaller, M. A., Carvalhaes, C. G., Rhomberg, P. R., Desphande, L. M., & Castanheira, M. (2024). Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021). Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01141-23

Vancouver

Pfaller MA, Carvalhaes CG, Rhomberg PR, Desphande LM, Castanheira M. Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021). Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.01141-23

BibTeX
@article{Pfaller2024,
  author = {Pfaller, M A and Carvalhaes, C G and Rhomberg, P R and Desphande, L M and Castanheira, M},
  title = {Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021)},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  doi = {10.1128/jcm.01141-23}
}
Kostenlos starten →